Filing Details
- Accession Number:
- 0001562180-19-003051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-22 16:01:58
- Reporting Period:
- 2019-05-20
- Accepted Time:
- 2019-05-22 16:01:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404281 | Novus Therapeutics Inc. | NVUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705287 | J. Gregory Flesher | C/O Novus Therapeutics, Inc 19900 Macarthur Blvd., Suite 550 Irvine CA 92612 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-05-20 | 11,701 | $1.96 | 159,855 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-21 | 2,937 | $1.91 | 156,918 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units.
- This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
